Cefpodoxime Proxetil
Active substance: cefpodoxime proxetil
GRANULE, FOR SUSPENSION · CEFPODOXIME PROXETIL 50 mg/5mL
United StatesActive
Marketing holder: Aurobindo Pharma Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CEFPODOXIME PROXETIL · 50 mg/5mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3dcd-7a5e-8483-b2cfba192b49,01a1208c-4ab8-7511-ab07-ae6f902f7e92,01a1208c-9977-7322-bedc-77068f144fd8,01a1208c-ad04-7d70-ab49-84544941d057,01a1208c-fd83-7126-8c25-4484c510c074;count=28 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 65862-140
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 65862-140 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 65862-140 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 65862-140 · Verified 2026-10-09 · open in source